Lyophilized Sterile Vial
Tested: 99.3%
Current Lot: MV-2026-CJC10-03
High-Purity Lyophilized Peptide
CJC-1295 (No DAC / Mod GRF 1-29)
10mg / 5mL Lyophilized • HPLC Purity: 99.3% • Target: ≥ 99.0%
Modified GRF (1-29) is a synthetic 29-amino-acid GHRH analog with four amino acid substitutions that enhance enzymatic resistance compared to native GHRH.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula C152H252N44O42
Molecular Weight 3367.97 g/mol
CAS Registry # 863288-34-0
Peptide Sequence / Structure YADAIFTNSYRKVLGQLSARKLLQDIMSR
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-CJC10-03 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Purity (RP-HPLC) | 99.3% | RP-HPLC C18 Column | Conforms |
| Molecular Mass (MS) | 3368.1 Da | MALDI-TOF / ESI-MS | Conforms |
| Net Peptide Content | 10.15 mg | Quantitative AAA | Conforms |
| Endotoxin | < 0.05 EU/mg | LAL Kinetic | Conforms |
Biological Mechanism of Action
Selectively binds GHRH receptors on pituitary somatotropes, stimulating adenylate cyclase and cAMP generation to trigger physiological pulsatile GH release.
Research Focus Areas: GHRH Signaling Somatotrope Activation Pulsatile Release
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for CJC-1295 No DAC.